J Pedro‐Botet

685 total citations
31 papers, 478 citations indexed

About

J Pedro‐Botet is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, J Pedro‐Botet has authored 31 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 8 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Epidemiology. Recurrent topics in J Pedro‐Botet's work include Lipoproteins and Cardiovascular Health (9 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Cancer, Lipids, and Metabolism (4 papers). J Pedro‐Botet is often cited by papers focused on Lipoproteins and Cardiovascular Health (9 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Cancer, Lipids, and Metabolism (4 papers). J Pedro‐Botet collaborates with scholars based in Spain, Australia and Estonia. J Pedro‐Botet's co-authors include J Rubiés-Prat, Xavier Nogués, Mariano Sentı́, R. Romero, Juan J. Chillarón, Isabel Salinas, Anna Sanmartı́, David Benaiges, Jordi L. Reverter and Anna Lucas and has published in prestigious journals such as Diabetes Care, Scientific Reports and Kidney International.

In The Last Decade

J Pedro‐Botet

29 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Pedro‐Botet Spain 11 241 203 75 70 69 31 478
Pin‐Ming Liu China 15 113 0.5× 130 0.6× 91 1.2× 76 1.1× 111 1.6× 50 563
Hendrick E. van Deventer South Africa 11 354 1.5× 317 1.6× 55 0.7× 121 1.7× 66 1.0× 13 780
J.F. Ascaso Spain 14 174 0.7× 251 1.2× 102 1.4× 33 0.5× 94 1.4× 35 540
Dipesh Patel United Kingdom 12 176 0.7× 321 1.6× 65 0.9× 128 1.8× 148 2.1× 41 653
Ravi Dave United States 5 312 1.3× 263 1.3× 69 0.9× 31 0.4× 81 1.2× 9 604
Nobuharu Fujiwara Japan 15 83 0.3× 123 0.6× 95 1.3× 110 1.6× 92 1.3× 19 497
Annemarie Armani United States 8 305 1.3× 215 1.1× 90 1.2× 20 0.3× 85 1.2× 14 585
Osamah Hussein Israel 12 170 0.7× 158 0.8× 163 2.2× 23 0.3× 48 0.7× 21 514
Gerald Klose Germany 13 222 0.9× 218 1.1× 94 1.3× 32 0.5× 41 0.6× 43 547
Magdalena Rysz-Górzyńska Poland 13 89 0.4× 105 0.5× 49 0.7× 55 0.8× 111 1.6× 17 414

Countries citing papers authored by J Pedro‐Botet

Since Specialization
Citations

This map shows the geographic impact of J Pedro‐Botet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Pedro‐Botet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Pedro‐Botet more than expected).

Fields of papers citing papers by J Pedro‐Botet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Pedro‐Botet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Pedro‐Botet. The network helps show where J Pedro‐Botet may publish in the future.

Co-authorship network of co-authors of J Pedro‐Botet

This figure shows the co-authorship network connecting the top 25 collaborators of J Pedro‐Botet. A scholar is included among the top collaborators of J Pedro‐Botet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Pedro‐Botet. J Pedro‐Botet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bea, Ana M., Ana Cenarro, Itziar Lamíquiz-Moneo, et al.. (2024). Association of HDL cholesterol with all-cause and cardiovascular mortality in primary hypercholesterolemia. Atherosclerosis. 400. 118617–118617. 4 indexed citations
2.
Núñez-Cortés, Jesús Millán & J Pedro‐Botet. (2021). Atherogenic dyslipidaemia: the other pandemic, associated with diabesity. Clínica e Investigación en Arteriosclerosis (English Edition). 33(1). 30–32. 3 indexed citations
3.
Barrios, Clara, Jonas Zierer, Peter Würtz, et al.. (2018). Circulating metabolic biomarkers of renal function in diabetic and non-diabetic populations. Scientific Reports. 8(1). 15249–15249. 45 indexed citations
4.
Roux, Juana A. Flores‐Le, David Benaiges, Gemma Llauradó, et al.. (2018). Previous Gestational Diabetes Increases Atherogenic Dyslipidemia in Subsequent Pregnancy and Postpartum. Lipids. 53(4). 387–392. 11 indexed citations
7.
Chillarón, Juan J., et al.. (2017). Hypertriglyceridemic waist in type 1 diabetes patients: prevalence and related factors. Minerva Endocrinology. 42(1). 1–7. 2 indexed citations
8.
Pedro‐Botet, J, et al.. (2016). Severity of statin-induced adverse effects on muscle and associated conditions: data from the DAMA study. Expert Opinion on Drug Safety. 15(12). 1583–1587. 17 indexed citations
9.
Iglesias, Pedro, J Pedro‐Botet, Francisco Arrieta, Manuel Aguilar‐Diosdado, & Fernando Escobar. (2015). Clinical Significance of the New Cardiovascular Risk Markers in Diabetes Mellitus. Current Diabetes Reviews. 11(4). 273–280. 4 indexed citations
10.
Chillarón, Juan J., et al.. (2015). Obesity and type 1 diabetes mellitus management.. PubMed. 40(1). 53–60. 20 indexed citations
11.
Antoñanzas, Fernando, J Pedro‐Botet, Ramón Coll, & Carlos Lahoz. (2013). Aneurisma aórtico. Clínica e Investigación en Arteriosclerosis. 25(5). 224–230. 4 indexed citations
12.
Joven, Jorge, Eugènia Espinel, Anna Rull, et al.. (2012). Metformin: a cheap and well‐tolerated drug that provides benefits for viral infections. HIV Medicine. 14(4). 233–240. 15 indexed citations
13.
Pedro‐Botet, J, et al.. (2005). W12-P-052 Clinical hypertension in HIV infected patients: Prevalence and related factors. Atherosclerosis Supplements. 6(1). 74–74. 1 indexed citations
14.
Masó, Silvia Mínguez, et al.. (1996). Idiopathic Bilateral Diaphragmatic Paralysis: Effectiveness of Bilevel Intermittent Positive Airway Pressure. Respiration. 63(5). 312–313. 1 indexed citations
15.
Sentı́, Mariano, et al.. (1992). Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure. Kidney International. 41(5). 1394–1399. 84 indexed citations
16.
Pedro‐Botet, J, et al.. (1992). Pulmonary tuberculosis in HIV-infected patients with normal chest radiographs. AIDS. 6(1). 91–94. 30 indexed citations
17.
Pedro‐Botet, J, et al.. (1991). Ciprofloxacin and immunocomplex-mediated disease.. PubMed. 230(6). 550–1. 2 indexed citations
18.
Sauleda, Jaume, et al.. (1990). [Dysphagia as the form of presentation of Forestier-Rotés disease].. PubMed. 187(5). 238–40. 3 indexed citations
19.
Cervantes, Francisco, et al.. (1985). Sequential Appearance of Immunoblastic Lymphoma and Acute Nonlymphocytic Leukemia in a Patient with Angioimmunoblastic Lymphadenopathy. Acta Haematologica. 74(3). 175–177. 1 indexed citations
20.
Pedro‐Botet, J, et al.. (1979). [Asthma and nitrofurantoin].. PubMed. 152(3). 235–7.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026